| Name | Title | Contact Details |
|---|---|---|
Scott Bromander |
Chief Product and Technology Officer | Profile |
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
CHCS Services, Inc. is a leading administrator of senior market insurance and eldercare programs. With a wealth of experience in the Medicare Supplement and long term care markets, our senior management team is dedicated to ensuring that CHCS Services
Audiology Hearing Care Services is a Martinsburg, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Exemplar Pharmaceuticals is a Fall River, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sadra Medical is a Los Gatos, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.